Colon Cancer Clinical Trial

Adaptive Randomization of Aerobic Exercise During Chemotherapy in Colon Cancer

Summary

To goal of this clinical trial is to quantify the dose-response effects of aerobic exercise training compared to attention control on chemotherapy relative dose intensity in colon cancer survivors.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Age ≥18 years
Histologically confirmed stage II or III colon cancer
Completed surgical resection with curative intent
Plan to initiate chemotherapy
Engage in <60 minutes per week of moderate- to vigorous-intensity structured aerobic exercise
No planned major surgery during the study period
Readiness to exercise, as determined by a modified version of the Physical Activity Readiness Questionnaire
Can walk 400 meters
Can read and speak English
Ability to provide written informed consent
Provide written approval by qualified healthcare professional
Willing to be randomized

Exclusion Criteria:

Evidence of metastatic colon cancer
Concurrently actively treated other (non-colon) cancer
Currently pregnant, breastfeeding, or planning to become pregnant within the next 24 weeks
Currently participating in another study with competing outcomes
Any other condition that, in the opinion of the investigator, would preclude participation or successful compliance with the protocol
Any other situation that, in the opinion of the investigator, would negatively impact subject safety or successful compliance with the protocol

Study is for people with:

Colon Cancer

Estimated Enrollment:

219

Study ID:

NCT05773144

Recruitment Status:

Recruiting

Sponsor:

Pennington Biomedical Research Center

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 3 Locations for this study

See Locations Near You

Kaiser Permanente Northern California
Oakland California, 94612, United States More Info
Michelle Ross
Contact
[email protected]
Bette J Caan, Dr.P.H.
Principal Investigator
Pennington Biomedical Research Center
Baton Rouge Louisiana, 70808, United States More Info
John Brown
Contact
[email protected]
Justin C Brown, Ph.D.
Principal Investigator
Dana-Farber Cancer Institute
Boston Massachusetts, 02215, United States More Info
Amalia Perez
Contact
[email protected]
Jeffrey A Meyerhardt, M.D.
Principal Investigator

How clear is this clinincal trial information?

Study is for people with:

Colon Cancer

Estimated Enrollment:

219

Study ID:

NCT05773144

Recruitment Status:

Recruiting

Sponsor:


Pennington Biomedical Research Center

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.